| [1] | Jinni HUANG, Jianning JIANG, Dandan LIANG, Shiyu LONG, Guozhen DONG, Man SU, Jijiao LI, Chunling TENG, Ping ZHANG, Minghua SU. Epidemiological features and antiviral response of genotype 6 chronic hepatitis C[J]. Journal of Clinical Hepatology, 2022, 38(4): 793-797. doi: 10.3969/j.issn.1001-5256.2022.04.011 |
| [2] | Rui HAN, Liaoyun ZHANG. Clinical epidemiology and pathological features of cryptogenic cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1650-1653. doi: 10.3969/j.issn.1001-5256.2022.07.036 |
| [3] | Shan SHAN, Lianhui ZHAO, Hong MA, Xiaojuan OU, Hong YOU, Jidong JIA. Definition, etiology, and epidemiology of liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 14-16. doi: 10.3969/j.issn.1001-5256.2021.01.003 |
| [4] | Li Jing, Wang YuFang. Epidemiological features of inflammatory bowel disease with hepatobiliary and pancreatic diseases[J]. Journal of Clinical Hepatology, 2020, 36(7): 1461-1466. doi: 10.3969/j.issn.1001-5256.2020.07.005 |
| [5] | Hao DaAng, Liu Ye, Shen ShanShan, Yan XueBing. An excerpt of AISF position paper on HCV in immunocompromised patients (2018)[J]. Journal of Clinical Hepatology, 2019, 35(4): 755-761. doi: 10.3969/j.issn.1001-5256.2019.04.010 |
| [6] | Shu YunRan, Li JunQi, Liu Qiong. Epidemiology of nonalcoholic fatty liver disease and related risk factors[J]. Journal of Clinical Hepatology, 2019, 35(9): 2085-2090. doi: 10.3969/j.issn.1001-5256.2019.09.045 |
| [7] | Hu JiangFeng, Lu LunGen. Research advances in the epidemiological features, pathogenesis, and diagnosis and treatment of alcoholic pancreatitis[J]. Journal of Clinical Hepatology, 2019, 35(2): 448-450. doi: 10.3969/j.issn.1001-5256.2019.02.047 |
| [8] | Shen Tao, Huang Xin, Wang YuYa, Zhuang Hui. Current status of epidemiological studies on drug-induced liver injury in China[J]. Journal of Clinical Hepatology, 2018, 34(6): 1152-1155. doi: 10.3969/j.issn.1001-5256.2018.06.002 |
| [9] | Li Jie. Epidemiology characteristics of nonalcoholic fatty liver disease in Asia[J]. Journal of Clinical Hepatology, 2018, 34(12): 2515-2519. doi: 10.3969/j.issn.1001-5256.2018.12.006 |
| [10] | Ding YuPing, Li Hai, Zhang Wen, Xia ShiHai, Bi Xun. Epidemiological characteristics of nonalcoholic fatty liver disease with elevated alanine aminotransferase and related risk factors[J]. Journal of Clinical Hepatology, 2017, 33(12): 2355-2360. doi: 10.3969/j.issn.1001-5256.2017.12.020 |
| [11] | Zhang YanFang, Zhao DongMei, Zhang YanMin, Wang Wei, Zhao HongRu. An analysis of related factors for hepatitis C genotyping and sustained virologic response in Xingtai, China[J]. Journal of Clinical Hepatology, 2015, 31(11): 1845-1848. doi: 10.3969/j.issn.1001-5256.2015.11.018 |
| [12] | Wang LiFeng, Li YuanYuan, Jin Lei, Wang FuSheng. Epidemiology and natural history of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 165-170. doi: 10.3969/j.issn.1001-5256.2015.02.005 |
| [13] | Zheng DongChun, Nie YuanXia, Liang HaiLin, Hu YueLin, Cheng Xiao, Feng XiaoXia, Chen YongPing. Epidemiological features and serological changes in sporadic acute hepatitis B among adults: an analysis of 202 cases[J]. Journal of Clinical Hepatology, 2014, 30(1): 30-33. doi: 10.3969/j.issn.1001-5256.2014.01.009 |
| [14] | Huang YanWu, Han FengJuan. Epidemiological features and disease spectrum of hepatitis C in Qinghai Province, China: analysis of 110 cases[J]. Journal of Clinical Hepatology, 2014, 30(6): 505-507. doi: 10.3969/j.issn.1001-5256.2014.06.007 |
| [15] | Chen HuiJuan, Zhao ShouSong. Recent insights into the roles of regulatory T cells in viral hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(11): 868-871. |
| [16] | Tian Di, Xu XiaoYuan. Treatment of hepatitis C virus infection in HIV/HCV co-infected patients[J]. Journal of Clinical Hepatology, 2011, 27(5): 540-544. |
| [17] | Yan Yan, Xiu BingShui, Yin JiMing, Zhang HeQiu, Li Zhuo. Evaluation of cross-reactive antibody response to hypervariable region 1 of hepatitis C virus[J]. Journal of Clinical Hepatology, 2011, 27(8): 818-820. |
| [18] | Qi ZhongTian. Hepatitis C virus infection and its therapeutic drugs[J]. Journal of Clinical Hepatology, 2011, 27(1): 15-18+27. |
| [19] | Yang RuiFeng, Wei Lai. Detection of hepatitis C virus infection[J]. Journal of Clinical Hepatology, 2011, 27(1): 1-7. |
| [20] | Guan Jie, Tan WenJie. The immunological evaluation of hepatitis C virus vaccine[J]. Journal of Clinical Hepatology, 2011, 27(1): 23-27. |
DownLoad: